These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11081554)

  • 1. Growth and autoantibodies to IA-2 in children with type 1 diabetes.
    Cianfarani S; Bonfanti R; Manca Bitti ML; Chiumello G; Boscherini B
    Lancet; 2000 Oct; 356(9240):1521. PubMed ID: 11081554
    [No Abstract]   [Full Text] [Related]  

  • 2. Comments on the relation among GAD-65, IA-2 antibodies and body adiposity.
    Porte D; Seeley RJ; Woods SC; Baskin DG; Figlewicz DP; Schwartz MW
    Diabetologia; 2000 Jan; 43(1):134. PubMed ID: 10672457
    [No Abstract]   [Full Text] [Related]  

  • 3. Autoantigens IA-2 and GAD in Type I (insulin-dependent) diabetes.
    Leslie RD; Atkinson MA; Notkins AL
    Diabetologia; 1999 Jan; 42(1):3-14. PubMed ID: 10027571
    [No Abstract]   [Full Text] [Related]  

  • 4. Autoantibodies to IA-2 not detected in NOD mice or BB rats.
    DeSilva MG; Jun HS; Yoon JW; Notkins AL; Lan MS
    Diabetologia; 1996 Oct; 39(10):1237-8. PubMed ID: 8897014
    [No Abstract]   [Full Text] [Related]  

  • 5. Autoantibodies to protein tyrosine phosphatase-like proteins in type I diabetes. Overlapping specificities to phogrin and ICA512/IA-2.
    Kawasaki E; Eisenbarth GS; Wasmeier C; Hutton JC
    Diabetes; 1996 Oct; 45(10):1344-9. PubMed ID: 8826969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IA-2 (islet cell antigen 512) is the primary target of humoral autoimmunity against type 1 diabetes-associated tyrosine phosphatase autoantigens.
    Bonifacio E; Lampasona V; Bingley PJ
    J Immunol; 1998 Sep; 161(5):2648-54. PubMed ID: 9725268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies directed against the ectodomain of ICA512: is there any evidence in patients with diabetes mellitus?
    Schiel R
    Diabetologia; 1998 Dec; 41(12):64-5. PubMed ID: 9867225
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between infant growth before onset of juvenile type-1 diabetes and autoantibodies to IA-2. Netherlands Kolibrie study group of childhood diabetes.
    Bruining GJ
    Lancet; 2000 Aug; 356(9230):655-6. PubMed ID: 10968443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies in insulin-dependent diabetes recognize distinct cytoplasmic domains of the protein tyrosine phosphatase-like IA-2 autoantigen.
    Lampasona V; Bearzatto M; Genovese S; Bosi E; Ferrari M; Bonifacio E
    J Immunol; 1996 Sep; 157(6):2707-11. PubMed ID: 8805677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibody against ICA512 did not improve test sensitivity for slowly progressive IDDM in adults.
    Kasuga A; Ozawa Y; Maruyama T; Ishihara T; Amemiya S; Saruta T
    Diabetes Care; 1997 Apr; 20(4):679-80. PubMed ID: 9097008
    [No Abstract]   [Full Text] [Related]  

  • 11. Early development and spreading of autoantibodies to epitopes of IA-2 and their association with progression to type 1 diabetes.
    Naserke HE; Ziegler AG; Lampasona V; Bonifacio E
    J Immunol; 1998 Dec; 161(12):6963-9. PubMed ID: 9862731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.
    Sabbah E; Savola K; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1999 May; 84(5):1534-9. PubMed ID: 10323375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
    Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
    J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does antibody combination really predict IDDM in the general population? Fortune telling--not fortune spending.
    Pinhas-Hamiel O; Sprecher E; Vardi P
    Diabetes Metab Rev; 1998 Sep; 14(3):252-4. PubMed ID: 9816473
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes.
    Steinbrenner H; Lohmann T; Ostendorf B; Scherbaum WA; Seissler J
    Diabetologia; 2000 Nov; 43(11):1381-4. PubMed ID: 11126406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of diabetes-specific autoantibodies in parents of children with type 1 diabetes. DENIS study group.
    Seissler J; Atik Y; Klinghammer A; Scherbaum WA
    Horm Metab Res; 1999 Dec; 31(12):657-61. PubMed ID: 10668918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies predicting diabetes mellitus type I in celiac disease.
    Galli-Tsinopoulou A; Nousia-Arvanitakis S; Dracoulacos D; Xefteri M; Karamouzis M
    Horm Res; 1999; 52(3):119-24. PubMed ID: 10725775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enterovirus infection may induce humoral immune response reacting with islet cell autoantigens in humans.
    Härkönen T; Paananen A; Lankinen H; Hovi T; Vaarala O; Roivainen M
    J Med Virol; 2003 Mar; 69(3):426-40. PubMed ID: 12526055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Value of antibodies to islet protein tyrosine phosphatase-like molecule in predicting type 1 diabetes.
    Hawa M; Rowe R; Lan MS; Notkins AL; Pozzilli P; Christie MR; Leslie RD
    Diabetes; 1997 Aug; 46(8):1270-5. PubMed ID: 9231650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-parameter model for prediction of type I diabetes mellitus.
    Eisenbarth GS; Gianani R; Yu L; Pietropaolo M; Verge CF; Chase HP; Redondo MJ; Colman P; Harrison L; Jackson R
    Proc Assoc Am Physicians; 1998; 110(2):126-35. PubMed ID: 9542768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.